MIR3198-1

Across TCGA pan-cancer cohorts, MIR3198-1 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of MIR3198-1’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where MIR3198-1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR3198-1 is over-expressed in tumor, although a few such as READ show the opposite, repressed pattern.

KIRC, STAD, and LUSC are the cancer types where MIR3198-1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR3198-1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	All	+0.128	.002	7	view →
STAD	All	All	+0.596	.001	5	view →
LUSC	All	II,III,IV	+0.482	.006	3	view →
READ	All	III,IV	−0.810	.021	2	view →
COAD	All	IV	+0.752	.031	2	view →
ESCA	All	All	+0.678	.043	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

MIR3198-1–KIRC

Open the KIRC breakdown →